Inventor
Part Peterson
Inventor
Tallinn, EE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
10,875,916Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F202010,131,709Nucleic acid molecules encoding monoclonal antibodies specific for IL-2220189,957,319Method of isolating human antibodies20189,475,872'Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F'20167,785,789'Gene defective in APECED and its use'20107,217,806'Gene defective in APECED and its use'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2010Patents assigned to FINNISH IMMUNOTECHNOLOGY LTD (2)· patent assignee history
2007–2010Based in Kaskitie, FI· patent location history
2016–2020Patents assigned to IMMUNOQURE AG (4)· patent assignee history
2016–2020Based in Tallinn, EE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOQURE AG | 4 | 2016–2020 |
| FINNISH IMMUNOTECHNOLOGY LTD | 2 | 2007–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tallinn, EE | 4 | 2016–2020 |
| Kaskitie, FI | 2 | 2007–2010 |